Literature DB >> 3313010

The first intron in the human c-abl gene is at least 200 kilobases long and is a target for translocations in chronic myelogenous leukemia.

A Bernards1, C M Rubin, C A Westbrook, M Paskind, D Baltimore.   

Abstract

The c-abl protooncogene is unusual in two respects; it has multiple, widely space N-terminal coding exons transcribed by different promoters, and it is the target of the translocations that form the Philadelphia chromosome found in cells of chronic myelogenous leukemia patients. To understand the organization of the gene in normal and chronic myelogenous leukemia patient DNA we have mapped c-abl by pulsed field gradient gel electrophoresis. We find that one of the alternative 5' exons of the gene lies at least 200 kilobases upstream of the remaining c-abl exons, posing formidable transcription and splicing problems. The 5'-most c-abl exon includes an unusually long 1,276-base-pair segment that contains 15 ATG codons and multiple short open reading frames, upstream of the abl initiator codon. Its peculiar structure suggests that c-abl may be decapitated in most chronic myelogenous leukemia patients, and we demonstrate that this is the case in the chronic myelogenous leukemia cell line K562.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3313010      PMCID: PMC367959          DOI: 10.1128/mcb.7.9.3231-3236.1987

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  29 in total

1.  Lymphosarcoma: virus-induced thymic-independent disease in mice.

Authors:  H T Abelson; L S Rabstein
Journal:  Cancer Res       Date:  1970-08       Impact factor: 12.701

2.  Three regions upstream from the cap site are required for efficient and accurate transcription of the rabbit beta-globin gene in mouse 3T6 cells.

Authors:  P Dierks; A van Ooyen; M D Cochran; C Dobkin; J Reiser; C Weissmann
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

3.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

4.  Drosophila melanogaster DNA clones homologous to vertebrate oncogenes: evidence for a common ancestor to the src and abl cellular genes.

Authors:  H Hoffman-Falk; P Einat; B Z Shilo; F M Hoffmann
Journal:  Cell       Date:  1983-02       Impact factor: 41.582

5.  Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: studies with cloned viral DNA.

Authors:  S P Goff; E Gilboa; O N Witte; D Baltimore
Journal:  Cell       Date:  1980-12       Impact factor: 41.582

6.  Two mammalian genes transcribed from opposite strands of the same DNA locus.

Authors:  J P Adelman; C T Bond; J Douglass; E Herbert
Journal:  Science       Date:  1987-03-20       Impact factor: 47.728

7.  Homology between phosphotyrosine acceptor site of human c-abl and viral oncogene products.

Authors:  J Groffen; N Heisterkamp; F H Reynolds; J R Stephenson
Journal:  Nature       Date:  1983 Jul 14-20       Impact factor: 49.962

8.  Abelson murine leukaemia virus protein is phosphorylated in vitro to form phosphotyrosine.

Authors:  O N Witte; A Dasgupta; D Baltimore
Journal:  Nature       Date:  1980-02-28       Impact factor: 49.962

9.  Cellular RNA homologous to the Abelson murine leukemia virus transforming gene: expression and relationship to the viral sequence.

Authors:  J Y Wang; D Baltimore
Journal:  Mol Cell Biol       Date:  1983-05       Impact factor: 4.272

10.  Rearrangement and amplification of c-abl sequences in the human chronic myelogenous leukemia cell line K-562.

Authors:  S J Collins; M T Groudine
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

View more
  36 in total

1.  Transformation of a novel direct-repeat repressor element into a promoter and enhancer by multimerisation.

Authors:  K C Chang; E Hansen; T Jaenicke; G Goldspink; P Butterworth
Journal:  Nucleic Acids Res       Date:  1992-04-11       Impact factor: 16.971

2.  Meiotic recombination between yeast artificial chromosomes yields a single clone containing the entire BCL2 protooncogene.

Authors:  G A Silverman; E D Green; R L Young; J I Jockel; P H Domer; S J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

3.  Differential transcription of exon 1 of the human c-fms gene in placental trophoblasts and monocytes.

Authors:  J Visvader; I M Verma
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

4.  Identification, characterization, and cell specificity of a human LINE-1 promoter.

Authors:  G D Swergold
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

Review 5.  Molecular analysis of the Philadelphia chromosome.

Authors:  A Dobrovic; G B Peters; J H Ford
Journal:  Chromosoma       Date:  1991-09       Impact factor: 4.316

Review 6.  An analysis of vertebrate mRNA sequences: intimations of translational control.

Authors:  M Kozak
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

7.  The 5' and 3' splice sites come together via a three dimensional diffusion mechanism.

Authors:  Z Pasman; M A Garcia-Blanco
Journal:  Nucleic Acids Res       Date:  1996-05-01       Impact factor: 16.971

8.  Interferon-alpha restores the deficient expression of the cytoadhesion molecule lymphocyte function antigen-3 by chronic myelogenous leukemia progenitor cells.

Authors:  G Upadhyaya; S C Guba; S A Sih; A P Feinberg; M Talpaz; H M Kantarjian; A B Deisseroth; S G Emerson
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

Review 9.  Antisense approaches to the gene therapy of cancer--'Recnac'.

Authors:  I Gibson
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

10.  Amplification of BCR protein associated with oncogenesis in human hepatocellular carcinoma.

Authors:  Y Miyazaki; T Mitsuma; T Ichida; H Odazima; K Ishihara; H Asakura
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.